Kupferberg HJ[au] - Search Results

Year	Number of Results
1963	1
1964	1
1968	2
1969	2
1970	1
1972	5
1973	3
1975	5
1977	1
1978	4
1979	4
1980	7
1981	4
1982	3
1983	2
1984	4
1985	6
1986	6
1987	2
1988	3
1989	1
1990	3
1992	1
1993	3
1995	5
1996	2
1997	1
1998	2
1999	2
2001	1
2002	2
2004	1
2005	1
2006	1
2007	2
2008	1
2015	1
2017	1
2021	0

1

Succinimides.

Ferrendelli JA, Kupferberg HJ. Ferrendelli JA, et al. Among authors: kupferberg hj. Adv Neurol. 1980;27:587-96. Adv Neurol. 1980. PMID: 6990713 Review. No abstract available.

2

Sodium valproate.

Kupferberg HJ. Kupferberg HJ. Adv Neurol. 1980;27:643-54. Adv Neurol. 1980. PMID: 6769305 Review. No abstract available.

3

The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and Beyond.

Porter RJ, Kupferberg HJ. Porter RJ, et al. Among authors: kupferberg hj. Neurochem Res. 2017 Jul;42(7):1889-1893. doi: 10.1007/s11064-017-2215-y. Epub 2017 Mar 9. Neurochem Res. 2017. PMID: 28275952 Review.

4

Antiepileptic Drug Development Program.

Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG. Porter RJ, et al. Among authors: kupferberg hj. Cleve Clin Q. 1984 Summer;51(2):293-305. doi: 10.3949/ccjm.51.2.293. Cleve Clin Q. 1984. PMID: 6380818 Clinical Trial. No abstract available.

5

The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models.

White HS, Johnson M, Wolf HH, Kupferberg HJ. White HS, et al. Among authors: kupferberg hj. Ital J Neurol Sci. 1995 Feb-Mar;16(1-2):73-7. doi: 10.1007/BF02229077. Ital J Neurol Sci. 1995. PMID: 7642355 Review.

6

The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy.

White HS, Wolf HH, Woodhead JH, Kupferberg HJ. White HS, et al. Among authors: kupferberg hj. Adv Neurol. 1998;76:29-39. Adv Neurol. 1998. PMID: 9408461 Review.

7

Preclinical testing.

Cereghino JJ, Kupferberg HJ. Cereghino JJ, et al. Among authors: kupferberg hj. Epilepsy Res Suppl. 1993;10:19-30. Epilepsy Res Suppl. 1993. PMID: 8251096 Review. No abstract available.

8

Mechanisms of action of anti-seizure drugs and the anticonvulsant screening program of the National Institute of Neurological Disorders and Stroke.

Porter RJ, Kupferberg HJ, Hessie BJ. Porter RJ, et al. Among authors: kupferberg hj. Int J Clin Pharmacol Ther. 2015 Jan;53(1):9-12. doi: 10.5414/CP202212. Int J Clin Pharmacol Ther. 2015. PMID: 25407259

9

Isoniazid as an inhibitor of primidone metabolism.

Sutton G, Kupferberg HJ. Sutton G, et al. Among authors: kupferberg hj. Neurology. 1975 Dec;25(12):1179-81. doi: 10.1212/wnl.25.12.1179. Neurology. 1975. PMID: 812007

10

Effect of methylphenidate on plasma anticonvulsant levels.

Kupferberg HJ, Jeffery W, Hunninghake DB. Kupferberg HJ, et al. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):201-4. doi: 10.1002/cpt1972132201. Clin Pharmacol Ther. 1972. PMID: 4552820 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results